Search results
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 5 days agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 7 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 7 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
BioNTech (NASDAQ:BNTX) PT Lowered to $122.00 at BMO Capital Markets
ETF DAILY NEWS· 3 days agoBioNTech (NASDAQ:BNTX – Free Report) had its price objective cut by BMO Capital Markets from $123.00 to $122.00 in a report released on Tuesday morning, Benzinga reports.
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 1 day agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
BioNTech shares hold rating, price target raised By Investing.com
Investing.com· 6 days agoTuesday, BioNTech SE (NASDAQ:BNTX) shares maintained their Hold rating, but with an updated price...
BioNTech reports net loss of €315.1m in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoBioNTech has experienced a significant shift in its financial standing, reporting a net loss of €315.1m ($339.3m) in the first quarter (Q1) of 2024. This...
BMO Capital cuts BioNTech stock target, keeps Outperform By Investing.com
Investing.com· 6 days agoOn Tuesday, BMO Capital Markets adjusted its price target for shares of BioNTech (NASDAQ:BNTX), a...